Monday, June 13, 2022 5:33:43 PM
Why was the NIH study on late stage patients? Who designed it?
Why wasn't it done with early stage to show that they improved and or did not advance to late stage. The testimonials we've all read about have been how it helped people improve. We see now that once the lung damage has happened, nothing will reverse it. It's kind of like testing a mini van on a race track
it's not meant for a race track. It should be tested for safety and reliability.
TIA
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM